Feasibility of idiotype vaccination in relapsed B-cell malignancies
2003
Feasibility of idiotype vaccination was statistically compared among five different B-cell malignancies in first relapse. When based on hybridoma production techniques, idiotypic vaccination for relapsed B-cell malignancies was consistently feasible only in follicular lymphoma patients, whereas the main cause of failure in other settings was the short survival of idiotype-producing hybridomas.
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
1
References
14
Citations
NaN
KQI